Combination therapy improves survival outcomes for patients with acute myeloid leukaemia
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over…
Browsing: AML
A new nanoconjugate blocks acute myeloid leukaemia tumour cells without harming healthy ones
Acute myeloid leukaemia (AML) is a heterogeneous disease which usual treatment is very aggressive and…
Blood cancer find raises new treatment hopes
New QIMR Berghofer research has identified how an early genetic change in blood and bone…
EHA 2020: A paradigm shift for the treatment of newly diagnosed older acute myeloid leukaemia patients
Acute myeloid leukaemia (AML) is primarily a disease of older adults. Standard commonly utilised lower-intensity…
Targeting stem cells that drive aggressive blood cancer
Peter Mac scientists have found a way to target acute myeloid leukemia (AML) at its…
Mutations in donors’ stem cells may cause problems for cancer patients
A stem cell transplant – also called a bone marrow transplant – is a common…
Vitamin B6, leukaemia’s deadly addiction
Scientists have discovered that Acute Myeloid Leukaemia (AML) grows by taking advantage of the B6…
Cocktail proves toxic to leukaemia cells
By Mike Williams, Rice University A combination of drugs that affect mitochondria—the power plants inside…
The potential of antihistamines in causing the death of leukaemic stem cells
Acute myeloid leukaemia (AML) has one of the worst prognosis of all leukaemias. Its treatment with chemotherapy…
Scanning for cancer treatment for AML
11,000 people are predicted to die from acute myeloid leukaemia (AML) in 2019, according to…